echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Sales of 5 star drugs have soared!

    Sales of 5 star drugs have soared!

    • Last Update: 2021-06-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
      Medical News, June 9th.
    Recently, national leaders proposed to "further develop traditional Chinese medicine.
    " Seven departments issued documents to support the export of traditional Chinese medicine.
    Traditional Chinese medicine has ushered in an unprecedented development opportunity

    .
    According to data from Meinenet, in 2020, the sales of proprietary Chinese medicines in retail pharmacies in cities in China will exceed 100 billion yuan.
    Respiratory diseases will lead the market, with China Resources Pharmaceuticals, Taiji Group, and Yunnan Baiyao as the main manufacturers

    .
    Among the TOP20 products, the sales of 11 products exceeded 1 billion yuan, and the sales of 5 star products soared; among the TOP20 brands, the sales of 11 brands all increased to varying degrees, and the two brands entered the one billion echelon for the first time.
    China Resources Pharmaceutical and Baiyunshan have the most brands on the list

    .
     
      100 billion retail Chinese patent medicine market, with respiratory disease drugs taking the lead
     
      In recent years, under the promotion of medical reform, capital and Internet technology , the pharmaceutical retail industry has continuously undergone new changes in its industry development and business model
    .
    In this context, the market growth of proprietary Chinese medicines in physical pharmacies has slowed down

    .
    According to data from Mi Nei.
    com, in 2020, the sales of proprietary Chinese medicines in physical pharmacies in cities in China exceeded 100 billion yuan, a year-on-year decline of 4.
    51%

    .
     
      Sales of proprietary Chinese medicines in physical pharmacies in cities in China (unit: 100 million yuan)
      Source: Mi Nei.
    com, China's urban physical pharmacy terminal competition pattern
     
      Among the 13 treatment categories of proprietary Chinese medicines, medicines for respiratory diseases ranked first with a market share of 26.
    6%.
    Affected by the new crown epidemic, the sales of cold and cough medicines in pharmacies have been restricted in various places, and the market size has dropped by 5.
    92%

    .
    The second and third-ranked digestive system disease drugs and cardiovascular and cerebrovascular disease drugs have a market share of more than 10%, and the market scale has further expanded

    .
     
      2020 China's urban physical pharmacies terminal TCM major category pattern
      Source: Mi Nei.
    com, China's urban physical pharmacy terminal competition pattern
     
      Among the top 20 proprietary Chinese medicine manufacturers, Donge Ejiao, China Resources Sanjiu Pharmaceutical , Taiji Group Chongqing Fuling Pharmaceutical, and Yunnan Baiyao Group all have sales of more than 2 billion yuan
    .
    The sales growth rate of three manufacturers exceeded 10%, including Shijiazhuang Yiling Pharmaceutical, Baiyunshan Hutchison Whampoa Traditional Chinese Medicine, and Yangzijiang Pharmaceutical Group

    .
     
      The market pattern of TOP20 proprietary Chinese medicine manufacturers in China's urban physical pharmacies in 2020
      Source: Mi Nei.
    com, China's urban physical pharmacy terminal competition pattern
     
      TOP20 proprietary Chinese medicines are released! 5 star product markets soared
     
      2020 China's urban entity pharmacy terminal TCM products TOP20
      Source: Mi Nei.
    com, China's urban physical pharmacy terminal competition pattern
     
      Among the TOP20 proprietary Chinese medicine products, 11 products have sales of more than 1 billion yuan, with donkey-hide gelatin, Angong Niuhuang pills, and Ganmaoling granules ranking the top three, with sales exceeding 2 billion yuan
    .
    Five products for cold medicine are on the list, and two products are on the list for blood tonic medicine, intestinal medicine, and heat-clearing and detoxifying medicine

    .
     
      Sales of five star products have soared, including Lianhua Qingwen Capsules, Banlangen Granules, Shuanghuanglian Oral Liquid, Pien Tze Huang and Antiviral Oral Liquid
    .
    Lianhua Qingwen Capsules, as a conventional treatment for new coronary pneumonia, will have a 148.
    59% increase in terminal sales in physical pharmacies in Chinese cities in 2020.
    Yiling Pharmaceutical's performance in 2020 will increase accordingly, with a net profit of 1.
    219 billion yuan, a year-on-year increase of 100.
    95%

    .
     
      Both Shuanghuanglian Oral Liquid and Banlangen Granules were sold out overnight due to the epidemic.
    In 2020, the terminal sales of physical pharmacies in Chinese cities increased by 39.
    98% and 30.
    02%, respectively

    .
    In January 2020, a joint study conducted by the Shanghai Institute of Materia Medica of the Chinese Academy of Sciences and the Wuhan Institute of Virology found that the Chinese patent medicine Shuanghuanglian oral liquid can inhibit the new coronavirus

    .
    In October 2020, Zhong Nanshan's team stated that in vitro studies have found that Baiyunshan compound Banlangen is effective against the new coronavirus

    .
    Both have shown inhibitory effects on the new coronavirus in in vitro experiments, and are still far from clinical trials conducted in humans

    .
     
      Pien Tze Huang is an exclusive product of Zhangzhou Pien Tze Huang Pharmaceutical.
    It has the effects of clearing away heat and detoxification, cooling blood and removing blood stasis, reducing swelling and pain.
    Various inflammations

    .
    In recent years, Pien Tze Huang has been the leading product in the terminal liver disease drug market in China's urban physical pharmacies, and its sales in 2020 will increase by 28.
    12% year-on-year.
     
      Anti-viral oral liquid is used for wind-heat cold, febrile fever, upper respiratory tract infection, influenza, mumps virus infection and other diseases
    .
    After the outbreak of the new crown epidemic, the anti-viral oral liquid was included in the national list of materials for the prevention and control of new coronavirus pneumonia, and was listed as a recommended drug for epidemic prevention and control by many provinces and cities

    .
    In 2020, the sales of terminal antiviral oral liquids in physical pharmacies in Chinese cities will increase by 22.
    30%, and Xiangxue Pharmaceutical will lead the market

    .
     
      China Resources, Tai Chi, Yangtze River.
    .
    .
    on the list of TOP20 proprietary Chinese medicine brands
     
      2020 China's urban physical pharmacy terminal TCM brand TOP20
      Source: Mi Nei.
    com, China's urban physical pharmacy terminal competition pattern
     
      Among the TOP20 proprietary Chinese medicine brands, 10 brands have sales of more than 1 billion yuan.
    Dong-E-E-Jiao's E-Jiao is still the leading product in the Chinese proprietary medicine market in physical pharmacies.
    Yiling Pharmaceutical's Lianhua Qingwen Capsules and Yangzijiang Pharmaceutical Group's Lanqin Oral liquid has entered the billion-dollar echelon for the first time

    .
     
      A total of 4 brands of China Resources Pharmaceutical's companies are on the list, and Baiyunshan has 2 brands on the list
    .
    From the perspective of the treatment field, 3 brands of blood-tonifying drugs are on the list, and 2 brands of cold drugs, intestinal drugs, cough and expectorant drugs, and cerebrovascular
    disease drugs are on the list
    .
     
      The sales of the 11 brands have increased to varying degrees.
    Jiangzhong Pharmaceutical's Jianweixiaoshi Tablets exceeded 1.
    4 billion yuan, and Taiji Group's Huoxiang Zhengqi Oral Liquid exceeded 1.
    2 billion yuan

    .
    In addition, the sales of Tiepi Fengdou Granules, an anti-cough, expectorant and anti-asthmatic drug of Zhejiang Emperor Pharmaceuticals, increased by 18.
    23%, thus successfully making the list of TOP20 proprietary Chinese medicine brands

    .
     
      Data source: Mi Nei.
    com, China's urban physical pharmacy terminal competition pattern
      Medical News, June 9th.
    Recently, national leaders proposed to "further develop traditional Chinese medicine.
    " Seven departments issued documents to support the export of traditional Chinese medicine.
    Traditional Chinese medicine has ushered in an unprecedented development opportunity

    .
    According to data from Meinenet, in 2020, the sales of proprietary Chinese medicines in retail pharmacies in cities in China will exceed 100 billion yuan.
    Respiratory diseases will lead the market, with China Resources Pharmaceuticals, Taiji Group, and Yunnan Baiyao as the main manufacturers

    .
    Among the TOP20 products, the sales of 11 products exceeded 1 billion yuan, and the sales of 5 star products soared; among the TOP20 brands, the sales of 11 brands all increased to varying degrees, and the two brands entered the one billion echelon for the first time.
    China Resources Pharmaceutical and Baiyunshan have the most brands on the list

    .
     
      100 billion retail Chinese patent medicine market, with respiratory disease drugs taking the lead
     
      In recent years, under the promotion of medical reform, capital and Internet technology , the pharmaceutical retail industry has continuously undergone new changes in its industry development and business model
    .
    In this context, the market growth of proprietary Chinese medicines in physical pharmacies has slowed down

    .
    According to data from Mi Nei.
    com, in 2020, the sales of proprietary Chinese medicines in physical pharmacies in cities in China exceeded 100 billion yuan, a year-on-year decline of 4.
    51%

    .
     
      Sales of proprietary Chinese medicines in physical pharmacies in cities in China (unit: 100 million yuan)
      Source: Mi Nei.
    com, China's urban physical pharmacy terminal competition pattern
     
      Among the 13 treatment categories of proprietary Chinese medicines, medicines for respiratory diseases ranked first with a market share of 26.
    6%.
    Affected by the new crown epidemic, the sales of cold and cough medicines in pharmacies have been restricted in various places, and the market size has dropped by 5.
    92%

    .
    The second and third-ranked digestive system disease drugs and cardiovascular and cerebrovascular disease drugs have a market share of more than 10%, and the market scale has further expanded

    .
     
      2020 China's urban physical pharmacies terminal TCM major category pattern
      Source: Mi Nei.
    com, China's urban physical pharmacy terminal competition pattern
     
      Among the top 20 proprietary Chinese medicine manufacturers, Donge Ejiao, China Resources Sanjiu Pharmaceutical , Taiji Group Chongqing Fuling Pharmaceutical, and Yunnan Baiyao Group all have sales of more than 2 billion yuan
    .
    The sales growth rate of three manufacturers exceeded 10%, including Shijiazhuang Yiling Pharmaceutical, Baiyunshan Hutchison Whampoa Traditional Chinese Medicine, and Yangzijiang Pharmaceutical Group

    .
     
      The market pattern of TOP20 proprietary Chinese medicine manufacturers in China's urban physical pharmacies in 2020
      Source: Mi Nei.
    com, China's urban physical pharmacy terminal competition pattern
     
      TOP20 proprietary Chinese medicines are released! 5 star product markets soared
     
      2020 China's urban entity pharmacy terminal TCM products TOP20
      Source: Mi Nei.
    com, China's urban physical pharmacy terminal competition pattern
     
      Among the TOP20 proprietary Chinese medicine products, 11 products have sales of more than 1 billion yuan, with donkey-hide gelatin, Angong Niuhuang pills, and Ganmaoling granules ranking the top three, with sales exceeding 2 billion yuan
    .
    Five products for cold medicine are on the list, and two products are on the list for blood tonic medicine, intestinal medicine, and heat-clearing and detoxifying medicine

    .
     
      Sales of five star products have soared, including Lianhua Qingwen Capsules, Banlangen Granules, Shuanghuanglian Oral Liquid, Pien Tze Huang and Antiviral Oral Liquid
    .
    Lianhua Qingwen Capsules, as a conventional treatment for new coronary pneumonia, will have a 148.
    59% increase in terminal sales in physical pharmacies in Chinese cities in 2020.
    Yiling Pharmaceutical's performance in 2020 will increase accordingly, with a net profit of 1.
    219 billion yuan, a year-on-year increase of 100.
    95%

    .
     
      Both Shuanghuanglian Oral Liquid and Banlangen Granules were sold out overnight due to the epidemic.
    In 2020, the terminal sales of physical pharmacies in Chinese cities increased by 39.
    98% and 30.
    02%, respectively

    .
    In January 2020, a joint study conducted by the Shanghai Institute of Materia Medica of the Chinese Academy of Sciences and the Wuhan Institute of Virology found that the Chinese patent medicine Shuanghuanglian oral liquid can inhibit the new coronavirus

    .
    In October 2020, Zhong Nanshan's team stated that in vitro studies have found that Baiyunshan compound Banlangen is effective against the new coronavirus

    .
    Both have shown inhibitory effects on the new coronavirus in in vitro experiments, and are still far from clinical trials conducted in humans

    .
     
      Pien Tze Huang is an exclusive product of Zhangzhou Pien Tze Huang Pharmaceutical.
    It has the effects of clearing away heat and detoxification, cooling blood and removing blood stasis, reducing swelling and pain.
    Various inflammations

    .
    In recent years, Pien Tze Huang has been the leading product in the terminal liver disease drug market in China's urban physical pharmacies, and its sales in 2020 will increase by 28.
    12% year-on-year.
     
      Anti-viral oral liquid is used for wind-heat cold, febrile fever, upper respiratory tract infection, influenza, mumps virus infection and other diseases
    .
    After the outbreak of the new crown epidemic, the anti-viral oral liquid was included in the national list of materials for the prevention and control of new coronavirus pneumonia, and was listed as a recommended drug for epidemic prevention and control by many provinces and cities

    .
    In 2020, the sales of terminal antiviral oral liquids in physical pharmacies in Chinese cities will increase by 22.
    30%, and Xiangxue Pharmaceutical will lead the market

    .
     
      China Resources, Tai Chi, Yangtze River.
    .
    .
    on the list of TOP20 proprietary Chinese medicine brands
     
      2020 China's urban physical pharmacy terminal TCM brand TOP20
      Source: Mi Nei.
    com, China's urban physical pharmacy terminal competition pattern
     
      Among the TOP20 proprietary Chinese medicine brands, 10 brands have sales of more than 1 billion yuan.
    Dong-E-E-Jiao's E-Jiao is still the leading product in the Chinese proprietary medicine market in physical pharmacies.
    Yiling Pharmaceutical's Lianhua Qingwen Capsules and Yangzijiang Pharmaceutical Group's Lanqin Oral liquid has entered the billion-dollar echelon for the first time

    .
     
      A total of 4 brands of China Resources Pharmaceutical's companies are on the list, and Baiyunshan has 2 brands on the list
    .
    From the perspective of the treatment field, 3 brands of blood-tonifying drugs are on the list, and 2 brands of cold drugs, intestinal drugs, cough and expectorant drugs, and cerebrovascular
    disease drugs are on the list
    .
     
      The sales of the 11 brands have increased to varying degrees.
    Jiangzhong Pharmaceutical's Jianweixiaoshi Tablets exceeded 1.
    4 billion yuan, and Taiji Group's Huoxiang Zhengqi Oral Liquid exceeded 1.
    2 billion yuan

    .
    In addition, the sales of Tiepi Fengdou Granules, an anti-cough, expectorant and anti-asthmatic drug of Zhejiang Emperor Pharmaceuticals, increased by 18.
    23%, thus successfully making the list of TOP20 proprietary Chinese medicine brands

    .
     
      Data source: Mi Nei.
    com, China's urban physical pharmacy terminal competition pattern
      Medical News, June 9th.
    Recently, national leaders proposed to "further develop traditional Chinese medicine.
    " Seven departments issued documents to support the export of traditional Chinese medicine.
    Traditional Chinese medicine has ushered in an unprecedented development opportunity

    .
    According to data from Meinenet, in 2020, the sales of proprietary Chinese medicines in retail pharmacies in cities in China will exceed 100 billion yuan.
    Respiratory diseases will lead the market, with China Resources Pharmaceuticals, Taiji Group, and Yunnan Baiyao as the main manufacturers

    .
    Among the TOP20 products, the sales of 11 products exceeded 1 billion yuan, and the sales of 5 star products soared; among the TOP20 brands, the sales of 11 brands all increased to varying degrees, and the two brands entered the one billion echelon for the first time.
    China Resources Pharmaceutical and Baiyunshan have the most brands on the list

    .
     
      100 billion retail Chinese patent medicine market, with respiratory disease drugs taking the lead
      100 billion retail Chinese patent medicine market, with respiratory disease drugs taking the lead
     
      In recent years, under the promotion of medical reform, capital and Internet technology , the pharmaceutical retail industry has continuously undergone new changes in its industry development and business model
    .
    In this context, the market growth of proprietary Chinese medicines in physical pharmacies has slowed down

    .
    According to data from Mi Nei.
    com, in 2020, the sales of proprietary Chinese medicines in physical pharmacies in cities in China exceeded 100 billion yuan, a year-on-year decline of 4.
    51%

    .
    Medicine, medicine, medicine
     
      Sales of proprietary Chinese medicines in physical pharmacies in cities in China (unit: 100 million yuan)
      Source: Mi Nei.
    com, China's urban physical pharmacy terminal competition pattern
     
      Among the 13 treatment categories of proprietary Chinese medicines, medicines for respiratory diseases ranked first with a market share of 26.
    6%.
    Affected by the new crown epidemic, the sales of cold and cough medicines in pharmacies have been restricted in various places, and the market size has dropped by 5.
    92%

    .
    The second and third-ranked digestive system disease drugs and cardiovascular and cerebrovascular disease drugs have a market share of more than 10%, and the market scale has further expanded

    .
     
      2020 China's urban physical pharmacies terminal TCM major category pattern
      Source: Mi Nei.
    com, China's urban physical pharmacy terminal competition pattern
     
      Among the top 20 proprietary Chinese medicine manufacturers, Donge Ejiao, China Resources Sanjiu Pharmaceutical , Taiji Group Chongqing Fuling Pharmaceutical, and Yunnan Baiyao Group all have sales of more than 2 billion yuan
    .
    The sales growth rate of three manufacturers exceeded 10%, including Shijiazhuang Yiling Pharmaceutical, Baiyunshan Hutchison Whampoa Traditional Chinese Medicine, and Yangzijiang Pharmaceutical Group

    .
    Medicine Medicine Medicine
     
      The market pattern of TOP20 proprietary Chinese medicine manufacturers in China's urban physical pharmacies in 2020
    Pharmacy drugstore
      Source: Mi Nei.
    com, China's urban physical pharmacy terminal competition pattern
     
      TOP20 proprietary Chinese medicines are released! 5 star product markets soared
      TOP20 proprietary Chinese medicines are released! 5 star product markets soared
     
      2020 China's urban entity pharmacy terminal TCM products TOP20
      Source: Mi Nei.
    com, China's urban physical pharmacy terminal competition pattern
     
      Among the TOP20 proprietary Chinese medicine products, 11 products have sales of more than 1 billion yuan, with donkey-hide gelatin, Angong Niuhuang pills, and Ganmaoling granules ranking the top three, with sales exceeding 2 billion yuan
    .
    Five products for cold medicine are on the list, and two products are on the list for blood tonic medicine, intestinal medicine, and heat-clearing and detoxifying medicine

    .
     
      Sales of five star products have soared, including Lianhua Qingwen Capsules, Banlangen Granules, Shuanghuanglian Oral Liquid, Pien Tze Huang and Antiviral Oral Liquid
    .
    Lianhua Qingwen Capsules, as a conventional treatment for new coronary pneumonia, will have a 148.
    59% increase in terminal sales in physical pharmacies in Chinese cities in 2020.
    Yiling Pharmaceutical's performance in 2020 will increase accordingly, with a net profit of 1.
    219 billion yuan, a year-on-year increase of 100.
    95%

    .
     
      Both Shuanghuanglian Oral Liquid and Banlangen Granules were sold out overnight due to the epidemic.
    In 2020, the terminal sales of physical pharmacies in Chinese cities increased by 39.
    98% and 30.
    02%, respectively

    .
    In January 2020, a joint study conducted by the Shanghai Institute of Materia Medica of the Chinese Academy of Sciences and the Wuhan Institute of Virology found that the Chinese patent medicine Shuanghuanglian oral liquid can inhibit the new coronavirus

    .
    In October 2020, Zhong Nanshan's team stated that in vitro studies have found that Baiyunshan compound Banlangen is effective against the new coronavirus

    .
    Both have shown inhibitory effects on the new coronavirus in in vitro experiments, and are still far from clinical trials conducted in humans

    .
     
      Pien Tze Huang is an exclusive product of Zhangzhou Pien Tze Huang Pharmaceutical.
    It has the effects of clearing away heat and detoxification, cooling blood and removing blood stasis, reducing swelling and pain.
    Various inflammations

    .
    In recent years, Pien Tze Huang has been the leading product in the terminal liver disease drug market in China's urban physical pharmacies, and its sales in 2020 will increase by 28.
    12% year-on-year.
     
      Anti-viral oral liquid is used for wind-heat cold, febrile fever, upper respiratory tract infection, influenza, mumps virus infection and other diseases
    .
    After the outbreak of the new crown epidemic, the anti-viral oral liquid was included in the national list of materials for the prevention and control of new coronavirus pneumonia, and was listed as a recommended drug for epidemic prevention and control by many provinces and cities

    .
    In 2020, the sales of terminal antiviral oral liquids in physical pharmacies in Chinese cities will increase by 22.
    30%, and Xiangxue Pharmaceutical will lead the market

    .
     
      China Resources, Tai Chi, Yangtze River.
    .
    .
    on the list of TOP20 proprietary Chinese medicine brands
      China Resources, Tai Chi, Yangtze River.
    .
    .
    on the list of TOP20 proprietary Chinese medicine brands
     
      2020 China's urban physical pharmacy terminal TCM brand TOP20
      Source: Mi Nei.
    com, China's urban physical pharmacy terminal competition pattern
     
      Among the TOP20 proprietary Chinese medicine brands, 10 brands have sales of more than 1 billion yuan.
    Dong-E-E-Jiao's E-Jiao is still the leading product in the Chinese proprietary medicine market in physical pharmacies.
    Yiling Pharmaceutical's Lianhua Qingwen Capsules and Yangzijiang Pharmaceutical Group's Lanqin Oral liquid has entered the billion-dollar echelon for the first time

    .
     
      A total of 4 brands of China Resources Pharmaceutical's companies are on the list, and Baiyunshan has 2 brands on the list
    .
    From the perspective of the treatment field, 3 brands of blood-tonifying drugs are on the list, and 2 brands of cold drugs, intestinal drugs, cough and expectorant drugs, and cerebrovascular
    disease drugs are on the list
    .
    Disease disease disease
     
      The sales of the 11 brands have increased to varying degrees.
    Jiangzhong Pharmaceutical's Jianweixiaoshi Tablets exceeded 1.
    4 billion yuan, and Taiji Group's Huoxiang Zhengqi Oral Liquid exceeded 1.
    2 billion yuan

    .
    In addition, the sales of Tiepi Fengdou Granules, an anti-cough, expectorant and anti-asthmatic drug of Zhejiang Emperor Pharmaceuticals, increased by 18.
    23%, thus successfully making the list of TOP20 proprietary Chinese medicine brands

    .
     
      Data source: Mi Nei.
    com, China's urban physical pharmacy terminal competition pattern
      
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.
    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent Echemi's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.